Herbal therapies and cardiac side effects

Progress in Cardiovascular Nursing

Volumn 23, Issue 4, 2008, Pages 187-190

  Flattery, Maureen ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR AGENT; DRUG DERIVATIVE; PLANT EXTRACT; SABAL EXTRACT; UBIDECARENONE; UBIQUINONE; VITAMIN;

CRATAEGUS; DRUG EFFECT; GINKGO BILOBA; HEART; HERB DRUG INTERACTION; HUMAN; HYPERICUM; METHODOLOGY; NURSE ATTITUDE; PATIENT EDUCATION; PHYTOTHERAPY; REVIEW;

CARDIOVASCULAR AGENTS; CRATAEGUS; GINKGO BILOBA; HEART; HERB-DRUG INTERACTIONS; HUMANS; HYPERICUM; NURSE'S ROLE; PATIENT EDUCATION AS TOPIC; PHYTOTHERAPY; PLANT EXTRACTS; UBIQUINONE; VITAMINS;

EID: 61949445178     PISSN: 08897204     EISSN: 17517117     Source Type: Journal    
DOI: 10.1111/j.1751-7117.2008.00014.x     Document Type: Article

References (29)

1. Zick SM, Blume A, Aaronson KD. The prevalence and pattern of complementary and alternative supplement use in individuals with chronic heart failure. J Card Fail. 2005;11:686-689.
2. Saw Palmetto Extract, 2008. Available from: http://en.wikipedia.org/wiki/ Saw_palmetto_extract. Accessed June 2, 2008.
3. Serenoa, 1922. Available from: http://www.henriettesherbal.com/eclectic/ felter/serenoa.html. Accessed May 30, 2008.
4. Buck AC. Phytotherapy for the prostate. Br J Urol. 1996;78:325-326.
5. Wilt TJ, Ishani A, Stark G, et al. Saw Palmetto extracts for treatment of benign prostatic hyperplasia. A systematic review. JAMA. 1998;280:1604-1609.
6. Bent S, Kane C, Shinohara K, et al. Saw palmetto for benign prostatic hyperplasia. N Engl J Med. 2006;354:557-566.
7. Saw Palmetto (Serenoa repens), 2008. Available from: http://www.nlm.nih.gov/medlineplus/print/druginfo/natural/ patient-sawpalmetto.html. Accessed May 30, 2008.
8. Gingko Biloba, 2008. Available from: http://en.wikipedia.org/wiki/ Ginkgo_biloba. Accessed June 2, 2008.
9. Sierpina VS, Wollschlaeger B, Blumenthal M. Ginkgo bilabo. Am Fam Phys. 2003;68:923-926.
10. Watanabe CM, Wolffram S, Ader P, et al. The in vivo neuromodulatory effects of the herbal medicine Ginkgo biloba. Proc Natl Acad Science USA. 2001;98:6577-6580.
11. Wettstein A. Cholinesterase inhibitors and ginkgo extracts-are they comparable in the treatment of dementia? Comparison of published placebo-controlled efficacy studies of at least six months' duration. Phytomedicine. 2000;6:393-401.
12. Pittler MH, Ernst E. Ginkgo biloba extract for the treatment of intermittent claudication: A meta analysis of randomized trials. Am J Med. 2000;108:276-281.
13. St. John's Wort, 2008. Available from: http://en.wikipedia.org/wiki/ Saint_John's_wort. Accessed June 4, 2008.
14. St. John's Wort, 2008. Available from: http://www.umm.edu/altmed/ articles/stjohns-wort-000276.htm. Accessed June 4, 2008.
15. Lawvere S, Mahoney MC. St. John's Wort. Am Fam Phys. 2005;2249-2254.
16. Line K, Ramirez G, Mulrow CD, et al. St. John's Wort for depression-an overview and meta-analysis of randomized clinical trials. BMJ. 1996;313:253-258.
17. Hawthorn, 2008. Available from: http://www.umm.edu/altmed/articles/ hawthorn-000256.htm. Accessed June 5, 2008.
18. Pittler MH, Guo R, Ernst E. Hawthorn extract for treating chronic heart failure. Cochrane Database Systematic Review. 2008;(1):CD005312.
19. Zick SM, Gillespie B, Aaronson KD. The effect of Crataegus oxyacantha special extract WS 1442 on clinical progression in patients with mild to moderate symptoms of heart failure. Eur J Heart Fail. 2008:587-593.
20. Hawthorn & CHF, 2008. Available from: http://altmed.creighton.edu/ hawthorne/. Accessed June 5, 2008.
21. Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE study research group. N Engl J Med. 1991;325:1468-1475.
22. Cohn JN, Goldstein SO, Greenberg BH, et al. A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone trial investigators. New Engl J Med. 1998;339:1810-1816.
23. Felker GM, O'Connor CM. Inotropic therapy for heart failure: An evidence-based approach. Am Heart J. 2001;142:393-401.
24. Coenzyme Q, 2008. Available from: http://en.wikipedia.org/wiki/ Coenzyme_Q. Accessed June 6, 2008.
25. Coenzyme Q10, 2008. Available from: http://www.mayoclinic.com/health/ coenzyme-q10/NS_patient-coenzymeq10. Accessed June 6, 2008.
26. Sarter B. Coenzyme Q10 and cardiovascular disease: A review. J Cardiovasc Nurs. 2002;16(4):9-20.
27. Sander S, Coleman I, Patel AA, et al. The impact of coenzyme q10 on systolic function in patients with chronic heart failure. J Card Fail. 2006;12:464-472.
28. Singh RB, Niaz MA, Rastogi SS, et al. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. J Hum Hypertens. 1999;13:203-208.
29. Singh RB, Wander GS, Rastogi A, et al. Randomized, double-blind placebo-controlled trial of coenzyme Q10 in patients with acute myocardial infarction. Cardiovasc Drugs Ther. 1998;12:347-353.